Krystal Miller Email

Analytical Chemist III - Analytical Team Lead . DisperSol (Aquired)

Current Roles

Employees:
58
Revenue:
$11.7M
About
DisperSol Technologies provides expertise in formulation and processing technologies for solubility/bioavailability enhancement of poorly water-soluble drug molecules. DisperSol possesses a unique portfolio of technologies for the production of solubility enhanced systems that includes DisperSol's proprietary KinetiSolâ„¢ technology. As a non-solvent, fusion-based process that minimizes thermal stress with highly efficient mixing, KinetiSolâ„¢ is uniquely positioned to generate amorphous solid dispersion systems with the most challenging APIs and with the broadest spectrum of pharmaceutical polymers. DisperSol has established a rapid KinetiSolâ„¢ feasibility program whereby the applicability of the process to any NCE can be determined rapidly and with relatively little API. Following a successful KinetiSolâ„¢ feasibility program, DisperSol is positioned to provide formulations development and manufacturing services to support clinical studies at all phases.
DisperSol (Aquired) Address
111 W Cooperative Way
Georgetown, TX
United States
DisperSol (Aquired) Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.